CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Deep Brain Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04184791
NCT04184791N/ACompleted
CompareCT.gov

Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease

Northwell Health·interventional·Posted Dec 4, 2019·Updated Mar 15, 2024

In Brief

A clinical study evaluating Deep Brain Stimulation for Parkinson Disease. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The objective of this study is to further the understanding and application of 60Hz subthalamic deep brain stimulation (STN-DBS) in Parkinson's patients with gait disorder. The investigators will achieve this through 2 study aims: 1. Determine the impact of 60Hz subthalamic deep brain stimulation on gait kinematics using wearable sensors 2. Develop machine learning models to predict optimal subthalamic deep brain stimulation frequency based on wearable sensors

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsParkinson Disease
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS), The University of Tennessee, Knoxville

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 4, 2019
Enrollment StartJan 15, 2020
Primary CompletionAug 31, 2022
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 6.6 years ago

Interventions

Deep Brain Stimulationdevice

Each DBS electrode contact will be reprogrammed in 60hz and High Frequency Stimulation (180hz) in the Levodopa ON (medicated) and OFF (unmedicated) conditions.